tiprankstipranks
Bone Therapeutics S.A. (GB:0R55)
LSE:0R55
UK Market
0R55
Bone Therapeutics
RESEARCH TOOLSreports

Bone Therapeutics (0R55) Income Statement

2 Followers

Bone Therapeutics Income Statement

Last quarter (Q4 2025), Bone Therapeutics's total revenue was €0.00, a decrease of -100.00% from the same quarter last year. In Q4, Bone Therapeutics's net income was €21.64M. See Bone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Jun 25Dec 23Dec 22Dec 21
Total Revenue
€ 0.00€ 0.00€ 543.00K€ 296.00K€ 312.00K
Gross Profit
€ 0.00€ -196.00K€ 543.00K€ 296.00K€ 987.00K
Operating Expenses
€ 1.32M€ 8.08M€ 7.38M€ 2.52M€ 1.18M
Depreciation and Amortization
€ 0.00€ 196.00K€ 234.00K€ 60.00K€ 13.00K
EBITDA
€ -1.32M€ -4.84M€ -6.80M€ -2.26M€ -864.00K
Operating Income
€ -1.32M€ -8.27M€ -7.04M€ -2.32M€ -1.19M
Other Income/Expenses
€ 22.26M€ 1.56M€ -21.99M€ -731.00K€ 205.00K
Pretax Income
€ 20.93M€ -6.71M€ -29.03M€ -3.05M€ -984.00K
Net Income
€ 20.93M€ -4.77M€ -28.78M€ -2.04M€ -984.00K
Per Share Metrics
Basic EPS
€ 0.03€ -0.02€ -0.21€ -0.02€ -0.05
Diluted EPS
€ 0.03€ -0.02€ -0.21€ -0.02€ -0.05
Weighted Average Shares Outstanding
 652.86M 231.34M 137.04M 120.13M 21.31M
Weighted Average Shares Outstanding (Diluted)
 652.86M 231.34M 137.04M 120.13M 21.31M
Currency in EUR

Bone Therapeutics Earnings and Revenue History